Earnings Call · Q2 FY2023·2023-08-02

Q2 23EPS +2.63%·Rev n/aQ1 23EPS -14.52%·Rev n/aQ4 22EPS -3.61%·Rev n/aQ3 22EPS -15.79%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Host/Investor Relations

David Stack — Chairman and Chief Executive Officer

Charles Reinhart — Chief Financial Officer

+2.0%1d on move date+3.4% vs SPY3d+9.7%5d+6.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access